The U.S. Food and Drug Administration (FDA) has announced its decision to revoke the authorization of Red No. 3 for use in food products and ingested pharmaceuticals, citing potential health risks associated with the synthetic dye.
Alcohol recommendations in the 2025 Dietary Guidelines for Americans could be the next big policy fight that no one is talking about.
Disabled scientists are trying to make research labs and fieldwork more accessible. They say labs and field sites aren’t designed to serve them.
Read about the availability of $71 million in DOE funding to support 25 research projects that seek to advance the use of QIS for high energy physics.
On Wednesday, the Food and Drug Administration banned red dye No. 3, additive in food that was banned from cosmetics in 1990.
If Democratic senators think leaving the door ajar for RFK Jr. will get them points for bipartisanship, I recommend they find those opportunities elsewhere.
The Food and Drug Administration (FDA) announced Wednesday it will ban Red No. 3, a common artificial food dye linked
Food manufacturers will soon be banned from using the common food additive Red Dye No. 3 under an FDA rule released on Wednesday. Why it matters: The move comes two years after a petition from consumer advocates including the Center for Science in the Public Interest pointed to studies showing a connection between the dye and increased risk for cancer in rats.
The incoming US president is expected to gut support for research on the environment and infectious diseases, but could buoy work in artificial intelligence, quantum research and space exploration.
The FDA issued a proposed rule Tuesday that would require food manufacturers to put "Nutrition Info" labels on the front of their packages stating whether the food inside contains a high, medium, or low level of sodium, saturated fat, and added sugars.
Xavier Becerra, who has led the Department of Health and Human Services, says federal agencies are outmatched in a world of “instantaneous information and disinformation.”
Public engagement and collaborative partnerships with the private sector “throughout the innovation pipeline” can help ensure that AI tools are being equitably used and deployed, HHS said in its AI strategic plan.